Yonathan Freund, MD, PhD1,2; Marine Cachanado, MSc3; Quentin Delannoy, MD2; Said Laribi, MD, PhD4; Youri Yordanov, MD, PhD1,5; Judith Gorlicki, MD6; Tahar Chouihed, MD, PhD7; Anne-Laure Féral-Pierssens, PhD8; Jennifer Truchot, MD, PhD9; Thibaut Desmettre, MD, PhD10; Celine Occelli, MD11; Xavier Bobbia, MD, PhD12; Mehdi Khellaf, MD, PhD13; Olivier Ganansia, MD14; Jérôme Bokobza, MD15; Frédéric Balen, MD16; Sebastien Beaune, MD, PhD17; Ben Bloom, MD, PhD18; Tabassome Simon, MD, PhD1,3; Alexandre Mebazaa, MD, PhD19,20,21
doi : 10.1001/jama.2020.19378
JAMA. 2020;324(19):1948-1956
Clinical guidelines for the early management of acute heart failure in the emergency department (ED) setting are based on only moderate levels of evidence, with subsequent low adherence to these guidelines.
Saud H. AlDubayan, MD1,2,3,4; Jake R. Conway, BSc1,2,5; Sabrina Y. Camp, BSc1,2; Leora Witkowski, PhD6; Eric Kofman, BSc1,2; Brendan Reardon, BSc1,2; Seunghun Han, BA1,2,7; Nicholas Moore, MD1,2; Haitham Elmarakeby, PhD1,2,8; Keyan Salari, MD, PhD9; Hani Choudhry, PhD10; Abdullah M. Al-Rubaish, MD11; Abdulsalam A. Al-Sulaiman, MD11; Amein K. Al-Ali, PhD11; Amaro Taylor-Weiner, PhD2,5; Eliezer M. Van Allen, MD1,2
doi : 10.1001/jama.2020.20457
JAMA. 2020;324(19):1957-1969
Less than 10% of patients with cancer have detectable pathogenic germline alterations, which may be partially due to incomplete pathogenic variant detection.
Aaron Reuben, MEM1; Maxwell L. Elliott, MA1; Wickliffe C. Abraham, PhD2; Jonathan Broadbent, PhD3; Renate M. Houts, PhD1; David Ireland, PhD4; Annchen R. Knodt, MS1; Richie Poulton, PhD4; Sandhya Ramrakha, PhD4; Ahmad R. Hariri, PhD1; Avshalom Caspi, PhD1,5,6,7,8; Terrie E. Moffitt, PhD1,5,6,7,8
doi : 10.1001/jama.2020.19998
JAMA. 2020;324(19):1970-1979
Childhood lead exposure has been linked to disrupted brain development, but long-term consequences for structural brain integrity are unknown.
Denis G. Arnold, PhD1; Oscar Jerome Stewart, PhD2; Tammy Beck, PhD3
doi : 10.1001/jama.2020.18740
JAMA. 2020;324(19):1995-1997
Andrea M. Lerner, MD, MS1; Gregory K. Folkers, MS, MPH1; Anthony S. Fauci, MD1
doi : 10.1001/jama.2020.21946
JAMA. 2020;324(19):1935-1936
Grace M. Lee, MD, MPH1; José R. Romero, MD2,3; Beth P. Bell, MD, MPH4
doi : 10.1001/jama.2020.19692
JAMA. 2020;324(19):1937-1938
Manish M. Patel, MD1; Michael L. Jackson, PhD2; Jill Ferdinands, PhD1
doi : 10.1001/jama.2020.19328
JAMA. 2020;324(19):1939-1940
Eli Y. Adashi, MD, MS1; I. Glenn Cohen, JD2
doi : 10.1001/jama.2020.19059
JAMA. 2020;324(19):1941-1942
Stephanie Parks Taylor, MD, MS1
doi : 10.1001/jama.2020.21746
JAMA. 2020;324(19):1943-1944
W. Gregory Feero, MD, PhD1,2,3
doi : 10.1001/jama.2020.19939
JAMA. 2020;324(19):1945-1947
Andrew T. Lenis, MD, MS1; Patrick M. Lec, MD1; Karim Chamie; MD, MSHS1
doi : 10.1001/jama.2020.17598
JAMA. 2020;324(19):1980-1991
Bladder cancer is a common malignancy in women and is the fourth most common malignancy in men. Bladder cancer ranges from unaggressive and usually noninvasive tumors that recur and commit patients to long-term invasive surveillance, to aggressive and invasive tumors with high disease-specific mortality.
Soumya Chatterjee, MD, MS1,2; Elliott Chandler Dasenbrook, MD, MHS1,3,4
doi : 10.1001/jama.2020.14648
JAMA. 2020;324(19):1992-1993
Mary Chris Jaklevic, MSJ
doi : 10.1001/jama.2020.21354
JAMA. 2020;324(19):1928-1930
Mary Chris Jaklevic, MSJ
doi : 10.1001/jama.2020.22066
JAMA. 2020;324(19):1934
Mary Chris Jaklevic, MSJ
doi : 10.1001/jama.2020.21458
JAMA. 2020;324(19):1934
Mary Chris Jaklevic, MSJ
doi : 10.1001/jama.2020.22068
JAMA. 2020;324(19):1934
Paul Shafer, PhD1; Austin B. Frakt, PhD1,2
doi : 10.1001/jama.2020.21609
JAMA. 2020;324(19):1931-1932
Bridget M. Kuehn, MSJ
doi : 10.1001/jama.2020.21109
JAMA. 2020;324(19):1933
Bridget M. Kuehn, MSJ
doi : 10.1001/jama.2020.22082
JAMA. 2020;324(19):1933
Bridget M. Kuehn, MSJ
doi : 10.1001/jama.2020.22085
JAMA. 2020;324(19):1933
Andrew T. Lenis, MD, MS1; Patrick M. Lec, MD1; Karim Chamie, MD, MSHS1
doi : 10.1001/jama.2020.17601
JAMA. 2020;324(19):2006
Suhas Gondi, BA1; Rishi K. Wadhera, MD, MPP, MPhil2
doi : 10.1001/jama.2020.19006
JAMA. 2020;324(19):1997-1998
Amol S. Navathe, MD, PhD1; Connor W. Boyle, BA1; Ezekiel J. Emanuel, MD, PhD1
doi : 10.1001/jama.2020.19021
JAMA. 2020;324(19):1998
Benjamin A. Goldstein, PhD1; Michael J. Pencina, PhD1
doi : 10.1001/jama.2020.19392
JAMA. 2020;324(19):1998-1999
Junfeng Wang, PhD1; Yue Li, MSc2
doi : 10.1001/jama.2020.19389
JAMA. 2020;324(19):1999-2000
Amin Adibi, MSc1; Mohsen Sadatsafavi, MD, PhD1; John P. A. Ioannidis, MD, DSc2
doi : 10.1001/jama.2020.19413
JAMA. 2020;324(19):2000
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟